-
Details
-
2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002
Series 2021
Series 2020
Series 2019
Series 2018
Board Regulation No. 1 |
Amending Section 1 of Board Regulation No. 4, Series of 2005 "Reclassifying Ephedrine and Pseudoephedrine as Dangerous Drugs" by including the Isomers and Salts of Isomers of Ephedrine and Pseudoephedrine and by including further their Halogenated and Alkylated forms thereof and the Salts, Isomers, and Salts of Isomers of these forms as well as any material, compound, mixture or preparation containing the same, in the list of Dangerous Drugs |
Board Regulation No. 2 |
Balay Silangan - Guidelines for Community Involvement in Reforming Drug Offenders into Self-sufficient and Law-abiding Members of Society |
Board Regulation No. 3 |
Amending Section 3 (2) of Board Regulation No. 1, Series of 2014 and Creating the Committee on Reclassification, Addition or Removal of any Drug/Substance from the List of Dangerous Drugs/Controlled Precursors and Essential Chemicals |
Board Regulation No. 4 |
Inclusion of 4-Methylethcathinone (4-MEC) in the List of Dangerous Drugs |
Board Regulation No. 5 |
Inclusion of 5F-APINACA (5-F-AKB-48) in the List of Dangerous Drugs |
Board Regulation No. 6 |
Inclusion of Ethylone in the List of Dangerous Drugs |
Board Regulation No. 7 |
Inclusion of Ethylphenidate in the List of Dangerous Drugs |
Board Regulation No. 8 |
Inclusion of MDMB-CHMICA in the List of Dangerous Drugs |
Board Regulation No. 9 |
Inclusion of Methiopropamine (MPA) in the List of Dangerous Drugs |
Board Regulation No. 10 |
Inclusion of Pentedrone in the List of Dangerous Drugs |
Board Regulation No. 11 |
Inclusion of XLR-11 in the List of Dangerous Drugs |
Board Regulation No. 12 |
Amending Section 2, Article II and Section 7(e), Article IV of Board Regulation No. 5 Series of 2003, Entitled: Guidelines in the Implementation of "Operation: Private Eye", as Further Amended by DDB Board Regulation No. 1 Series of 2005 and DDB Regulation No. 4 Series of 2007 |
Board Regulation No. 13 |
Establishment and Instituitionalization of Drug-Free Workplace Policies in all Government Offices, Including the Conduct of Authorized Drug Testing for Elective Local Officials and Appointive Public Officers and for other Purposes |
Series 2017
Series 2016
Series 2015
Series 2014
Board Regulation No.1 |
Comprehensive Amendments to Board Regulation No. 3 Series 2003, "Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, and Other Lawful Acts in Connection with Any Dangerous Drugs, Controlled Precursors and Essential Chemicals and Other Similar or Analogous Substances", as Amended, and Other Related Board Issuances. (This Board Regulation will take effect on March 13, 2015)
|
Series 2013
Board Regulation No.1 |
Amending Board Regulation No. 1, Series 2002, entitled "Guidelines on the Custody and Disposition of Seized Dangerous Drugs, Controlled Precursors and Essential Chemicals, and Laboratory Equipment" and for Other Purposes. |
Board Regulation No.2 |
Inclusion of Methylephedrine in the list of dangerous drugs. |
DRAFT PROPOSED AMENDMENT of Board Regulation No.3 |
Comprehensive Amendments to Board Regulation No. 3 s 2003, "Comprehensive Guidelines on importation, distribution, manufacture, prescription, dispensing and sale of, and other lawful acts in connection with any dangerous drugs, controlled precursors and essential chemicals and other similar or analogous substances", as amended, and other related Board issuances |
Board Regulation No. 4 Series of 2013 |
Amendment to Board Regulation No. 7, Series of 2003 Entitled "General Guidelines for the Implementation of Mandatory Drug Testing to Officers and Members of the Military, Police and Other Law Enforcement Agencies" |
Series 2010
Series 2009
Board Regulation No.1 |
Guidelines for the Rehabilitation of First Time Offenders Under Section 15 of RA 9165 Who Are Not Drug Dependents |
Board Regulation No.2 |
Implementing Guidelines for the Implementation of Board Regulation No. 6, Series of 2007, entitled Classifying Toluene-Based Contact Cement Products Without at Least Five Percent (5%) Mustard Oil Content as Dangerous Drugs |
Board Regulation No.3 |
General Guidelines for the Conduct of Random Drug Testing for Students of Secondary, Tertiary, Vocational and Technical Schools, Amending Board Regulation No.6, Series of 2003 |
Board Regulation No.4 |
Amending Section 18 and 19, Article III of Board Regulation No.3, Series of 2003, entitled "Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing and Sale of, and Other Lawful Acts in connection with, any Dangerous Drugs, Controlled Precursors and Essential Chemicals and Other Similar or Analogous Substances"
|
Board Regulation No.5 |
Inclusion of N-Benzylpiperazine (BZP) in the List of Dangerous Drugs |
Series 2008
Series of 2007
Board Regulation No.1 |
Guidelines on the Disposition of Confiscated, Seized and/or Surrendered Dangerous Drugs, Plant Sources of Dangerous Drugs, Controlled Precursors and Essential Chemicals, Instruments/Paraphernalia, and/or Laboratory Equipment in connection with Cases under Investigation, Preliminary Investigation or Reinvestigation |
Board Regulation No.2 |
Providing for Revised Guidelines in the Conduct of Barangay Drug-Clearing Operations
|
Board Regulation No.3 |
Rules Governing Voluntary Confinement for Treatment and Rehabilitation of Drug Dependents |
Board Regulation No.4 |
Amending certain Sections of Board Regulation No.5, Series of 2003, entitled Guidelines in the Implementation of Operation “Private Eye” as amended by Board Regulation No.4, Series of 2006 |
Board Regulation No.5 |
Institutionalizing the Barkada Kontra Droga Program |
Board Regulation No.6 |
Classifying Toluene-Based Contact Cement Products Without at Least Five Percent (5%) Mustard Oil Content as Dangerous Drugs |
Board Regulation No.7 |
Amending Board Regulation No.3, Series of 2003, entitled “Comprehensive Guidelines on Importation, Distribution, Manufacture, Prescription, Dispensing, and Sale of, and other Lawful Acts in connection with, any Dangerous Drugs, Controlled Precursors and Essential Chemicals and other Similar or Analogous Substances”
|
Board Regulation No.8 |
Amending Board Regulation No.2, Series of 2003, entitled “Implementing Rules and Regulations Governing Accreditation of Drug Testing Laboratories in the Philippines” |
Board Regulation No.9 |
Amending Board Regulation No.1, Series of 2004, entitled “Prescribing Drug Test Fee for Government-Owned and Private Drug Testing Laboratories Accredited by the Department of Health” |
Board Regulation No.10 |
Uniform Drug Inventory and Tracking System |
Series 2006
Series 2005
Series 2004
Series 2003
Series 2002